Scholars Central

Review articlePublished 27 Jul 2016

Treatment of Behcets disease

Authors: Erkan Alpsoy, Ayse Akman

Clinical Practice

Volume 3 · Issue 1 · Pages 139

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Behçet’s disease is a chronic, relapsing, systemic vasculitis of unknown etiology with the clinical features of mucocutaneous lesions and ocular, vascular, articular, gastrointestinal, urogenital, pulmonary and neurologic involvement. The disease is particularly prevalent in ‘Silk Route’ populations but has a global distribution. Behçet’s disease effects primarily young subjects. The diagnosis is based on clinical criteria, as there is no pathognomonic test. Besides considerable morbidity, the disease confers an increased mortality, mainly due to large vessel (especially pulmonary arterial) and neurologic involvement as well as bowel perforation. No standard therapy has yet been established for the treatment of Behçet’s disease, and a wide spectrum of therapeutic agents have been used with varying success. Treatment of the disease has become much more effective in recent years with the introduction of newer drugs. This paper will aim to provide an overview of the therapeutic approaches including local and systemic agents for the treatment of Behçet’s disease.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Clinical Practice.

All its articles

Article · 28 Mar 2025

Using

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Practice
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Erkan Alpsoy”
  • BylineArticles whose byline prints “Ayse Akman”